Mehai Technology (540730)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter is profitable: sales of ₹19 Cr and net profit of ₹2 Cr.
• ROCE of 13.62% suggests some capital efficiency at an operating level.
• Small market cap of ₹109 Cr leaves room for meaningful upside if the business genuinely stabilizes.

Concerns

• Sales and profit have collapsed by 57.60% and 61.28%, respectively.
• P/B of 41.36 against book value of ₹0.87 leaves no margin of safety.
• Piotroski F-Score of 3/9 indicates weak fundamental health.
• No dividend, undisclosed promoter holding, and a 52-week range of ₹1.13 to ₹35.98 point to speculation.

AI Analysis

At first glance, this is exactly the kind of stock I teach investors to avoid. Mehai Technology is in trading and distribution—a business where differentiation is rare and customers can squeeze your margins. The numbers confirm my caution. Sales have collapsed by 57.60% and profits by 61.28%. A business shrinking at this rate is not a compounding machine; it needs a clear turnaround plan, and I see no evidence of one. The valuation makes no sense to me. The stock trades at ₹35.98, which is 41.36 times book value of just ₹0.87. Graham taught me never to pay more than a reasonable multiple of assets for a company without exceptional earnings power. Here earnings power is falling. P/E of 20.74 might look moderate in isolation, but with profits down 61%, the denominator is unreliable. The 52-week range—₹1.13 to ₹35.98—tells me this is a speculative move, not an investment thesis. The Piotroski F-Score of 3 out of 9 is a red flag. It signals weak financial health across profitability, leverage, and efficiency. There is no dividend yield to compensate shareholders for risk. Promoter holding is not disclosed, so I cannot judge whether management's interests are aligned with mine. ROE of 7.96% is nothing special; an index fund can deliver similar long-term returns with less headache. ROCE of 13.62% is better, but not enough to justify 41 times book. The latest quarter shows sales of ₹19 Cr and net profit of ₹2 Cr, so the company is not dead. But one quarter does not reverse a 57% sales decline. If management can stabilize operations, improve F-Score, and rebuild book value, it might become interesting. Today, it is a pass. In investing, you don't need to act on every stock; you wait for the fat pitch.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer